pp.35-41 (7) Authors: Garry M. Walsh, Alexander J. Robinson, Ping Wu -- doi: 10.2174/1874838400801010035 -- Current therapies for asthma are aimed at controlling disease symptoms and for the majority of patients inhaled glucocorticoid anti-inflammatory therapy is both effective and well-tolerated. However, concerns remain about the adverse effects of glucocorticoids while a subset of asthmatic patients remains symptomatic despite optimal treatment thereby creating a clear unmet medical need.
WHAT IS SYMPOSIER?
Symposier.com is the technological platform that will allow you (and your colleagues) to share medical information, event calendars, clinical cases, new procedures and much more with medicine professionals around the world.
Get in touch with medical professionals around the world and seize the collective experiences and knowledge to the benefit of your own patients.
Establish common-interest groups to build a collaboration network
Learn, comment and publish about local or international medical events
Seize and publish to our video, image and medical documents library
Symposier uploaded this document.
Recent Developments in Targeting Eosinophil Accumulation as a Novel Therapeutic Approach for Asthma
Date: 19 Sep 2010
Uploader: Symposier
